How do we determine whether Anheuser-Busch InBev SA/NV (ADR) (NYSE:BUD) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense amounts of time and resources studying companies. They may not always be right (no one is), but data shows that their consensus long positions have historically outperformed the market when we adjust for known risk factors.
Is Anheuser-Busch InBev SA/NV (ADR) (NYSE:BUD) a buy here? Prominent investors are buying. The number of bullish hedge fund positions increased by 8 lately. BUD was in 49 hedge funds’ portfolios at the end of September. There were 41 hedge funds in our database with BUD positions at the end of the previous quarter. At the end of this article we will also compare BUD to other stocks including Bank of America Corp (NYSE:BAC), Nippon Telegraph & Telephone Corp (ADR) (NYSE:NTT), and Oracle Corporation (NASDAQ:ORCL) to get a better sense of its popularity.
With all of this in mind, we’re going to check out the latest action surrounding Anheuser-Busch InBev SA/NV (ADR) (NYSE:BUD).
How are hedge funds trading Anheuser-Busch InBev SA/NV (ADR) (NYSE:BUD)?
At Q3’s end, a total of 49 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 20% from the previous quarter. With the smart money’s sentiment swirling, there exists an “upper tier” of notable hedge fund managers who were boosting their stakes meaningfully (or already accumulated large positions).
When looking at the institutional investors followed by Insider Monkey, Eric W. Mandelblatt’s Soroban Capital Partners has the number one equity position in Anheuser-Busch InBev SA/NV (ADR) (NYSE:BUD), worth close to $971.7 million, comprising 7.1% of its total 13F portfolio. Other members of the smart money that hold long positions comprise of Tom Russo’s Gardner Russo & Gardner, Ken Fisher’s Fisher Asset Management and Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital.